Search research articles
Contact Us
Filters
Showing results (21-30 of 133) with videos related to
Page
of 14
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 17, 2007
Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
Sigurd Folkvord, Kjersti Flatmark, Therese Seierstad, et al.
Human Pathology
|
March 27, 2010
Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
Kjersti Flatmark, Ben Davidson, Alexandr Kristian, et al.
Clinical & Experimental Metastasis
|
September 22, 2019
Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei
Olaf Sørensen, Anders Mikal Andersen, Stein Gunnar Larsen, et al.
Neoplasia (New York, N.Y.)
|
May 31, 2007
Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice
Therese Seierstad, Sigurd Folkvord, Kathrine Røe, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
February 6, 2009
Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites
Gunhild M Maelandsmo, Vivi Ann Flørenes, Mai T P Nguyen, et al.
Annals of Surgical Oncology
|
August 11, 2025
Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer
Yvonne Andersson, Emil Løvstakken, Theodor Malmer Herud, et al.
BMC Cancer
|
July 28, 2016
Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
Erta Kalanxhi, Helga Helseth Hektoen, Sebastian Meltzer, et al.
BMC Cancer
|
August 21, 2014
B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
Vibeke A Ingebrigtsen, Kjetil Boye, Jahn M Nesland, et al.
The Journal of Surgical Research
|
August 9, 2005
Matrix metalloproteinases participate in osteosarcoma invasion
Kristin Bjørnland, Kjersti Flatmark, Solveig Pettersen, et al.
Cancers
|
July 2, 2021
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei-Still a Strong Preclinical Rationale
Yvonne Andersson, Karianne G Fleten, Torveig W Abrahamsen, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 133) with videos related to
Sort By:
Page
of 14
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 17, 2007
Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
Sigurd Folkvord, Kjersti Flatmark, Therese Seierstad, et al.
Human Pathology
|
March 27, 2010
Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
Kjersti Flatmark, Ben Davidson, Alexandr Kristian, et al.
Clinical & Experimental Metastasis
|
September 22, 2019
Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei
Olaf Sørensen, Anders Mikal Andersen, Stein Gunnar Larsen, et al.
Neoplasia (New York, N.Y.)
|
May 31, 2007
Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice
Therese Seierstad, Sigurd Folkvord, Kathrine Røe, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
February 6, 2009
Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites
Gunhild M Maelandsmo, Vivi Ann Flørenes, Mai T P Nguyen, et al.
Annals of Surgical Oncology
|
August 11, 2025
Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer
Yvonne Andersson, Emil Løvstakken, Theodor Malmer Herud, et al.
BMC Cancer
|
July 28, 2016
Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
Erta Kalanxhi, Helga Helseth Hektoen, Sebastian Meltzer, et al.
BMC Cancer
|
August 21, 2014
B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
Vibeke A Ingebrigtsen, Kjetil Boye, Jahn M Nesland, et al.
The Journal of Surgical Research
|
August 9, 2005
Matrix metalloproteinases participate in osteosarcoma invasion
Kristin Bjørnland, Kjersti Flatmark, Solveig Pettersen, et al.
Cancers
|
July 2, 2021
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei-Still a Strong Preclinical Rationale
Yvonne Andersson, Karianne G Fleten, Torveig W Abrahamsen, et al.
Page
of 14